All Phenotypes Plcg1<tm1Rwen> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0	either: B6.Cg-Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2)	MGI:4437917
cn2	Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0	involves: 129X1/SvJ * C57BL/6 * DBA/2	MGI:4437914
cn3	Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0	involves: 129X1/SvJ * C57BL/6 * DBA/2	MGI:4437915

Allelic Composition	Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0
Genetic Background	either: B6.Cg-Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plcg1^tm1Gcrp mutation (0 available); any Plcg1 mutation (48 available)
Plcg1^tm1Rwen mutation (0 available); any Plcg1 mutation (48 available)
Tg(Cd4-cre)1Cwi mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Plcg1^tm1Rwen/Plcg1^tm1Gcrp Tg(Cd4-cre)1Cwi/0 mice develop inflammatory/autoimmune disease

immune system

ear inflammation ( J:157757 )

increased CD4-positive, alpha-beta T cell number ( J:157757 )

• in the spleen and lymph nodes compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi mice

decreased T cell number ( J:157757 )

• peripheral T cells are reduced compared to in wild-type mice

decreased regulatory T cell number ( J:157757 )

• in the thymus and spleen compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi mice

abnormal T cell activation ( J:157757 )

• mice exhibit an increase in T cell activation compared with wild-type mice

• however, activation phenotype is not cell intrinsic

increased T cell proliferation ( J:157757 )

• mice exhibit a higher percentage of single positive T cells and splenic T cells than in wild-type mice

increased anti-double stranded DNA antibody level ( J:157757 )

• in symptomatic mice without an increase in anti-nuclear antibodies

skin inflammation ( J:157757 )

dermatitis ( J:157757 )

• in one third of mice

growth/size/body

decreased body size ( J:157757 )

• from 2 to 3 weeks

decreased body weight ( J:157757 )

• in female and male mice

digestive/alimentary system

rectal prolapse ( J:157757 )

• in one third of mice

hearing/vestibular/ear

ear inflammation ( J:157757 )

hematopoietic system

increased CD4-positive, alpha-beta T cell number ( J:157757 )

• in the spleen and lymph nodes compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi mice

decreased T cell number ( J:157757 )

• peripheral T cells are reduced compared to in wild-type mice

decreased regulatory T cell number ( J:157757 )

• in the thymus and spleen compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi mice

abnormal T cell activation ( J:157757 )

• mice exhibit an increase in T cell activation compared with wild-type mice

• however, activation phenotype is not cell intrinsic

increased T cell proliferation ( J:157757 )

• mice exhibit a higher percentage of single positive T cells and splenic T cells than in wild-type mice

integument

skin inflammation ( J:157757 )

dermatitis ( J:157757 )

• in one third of mice

alopecia ( J:157757 )

• in one third of mice

cellular

increased T cell proliferation ( J:157757 )

• mice exhibit a higher percentage of single positive T cells and splenic T cells than in wild-type mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

increased T cell apoptosis ( J:157757 )

• following reactivation

abnormal CD4-positive T cell differentiation ( J:157757 )

• differentiation into CD4 or CD8 single positive thymocytes is reduced compared to in wild-type mice

abnormal CD8-positive, alpha-beta T cell differentiation ( J:157757 )

• differentiation into CD4 or CD8 single positive thymocytes is reduced compared to in wild-type mice

increased double-positive T cell number ( J:157757 )

decreased T cell number ( J:157757 )

• peripheral T cells are reduced compared to in wild-type mice

• in transplantation experiments, T cells are less competitive than wild-type T cells

decreased CD4-positive, alpha-beta T cell number ( J:157757 )

• in the thymus

decreased CD8-positive, alpha-beta T cell number ( J:157757 )

• in the thymus

decreased single-positive T cell number ( J:157757 )

• CD4+ thymocytes are more profoundly decreased than CD8+ thymocytes

abnormal T cell activation ( J:157757 )

• mice exhibit an increase in T cell activation compared with wild-type mice

• however, activation phenotype is not cell intrinsic

decreased T cell proliferation ( J:157757 )

• in response to stimulation with anti-CD3m anti-CD3/anti-CD28, or anti-CD3/IL2, T cell proliferation is reduced compared to in similarly treated Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Gt(ROSA)26Sor^tm1(EYFP)Cos mice

• however, treatment with PMA/ionomycin restores proliferation

abnormal regulatory T cell physiology ( J:157757 )

• YFP+ T regulatory cells exhibit reduced ability to suppress naive T cell proliferation compared with wild-type T cells

decreased interferon-gamma secretion ( J:157757 )

• following anti-CD3/anti-CD28 stimulation, slightly fewer IFN-gamma producing single positive T cells are detected compared to in similarly treated Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Gt(ROSA)26Sor^tm1(EYFP)Cos mice

decreased interleukin-2 secretion ( J:157757 )

• following anti-CD3/anti-CD28 stimulation, IL2 production by single positive T cells is reduced compared to in similarly treated Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Gt(ROSA)26Sor^tm1(EYFP)Cos mice

dermatitis ( J:157757 )

• mice exhibit dermatitis unlike wild-type mice

• however, treatment with wild-type T regulatory cells prevents development of symptom

growth/size/body

decreased body weight ( J:157757 )

• mice weight less than wild-type mice

• however, transfer of regulatory T cells restores normal weight gain

digestive/alimentary system

rectal prolapse ( J:157757 )

• mice exhibit rectal prolapse unlike wild-type mice

• however, treatment with wild-type T regulatory cells prevents development of symptom

hematopoietic system

increased T cell apoptosis ( J:157757 )

• following reactivation

abnormal CD4-positive T cell differentiation ( J:157757 )

• differentiation into CD4 or CD8 single positive thymocytes is reduced compared to in wild-type mice

abnormal CD8-positive, alpha-beta T cell differentiation ( J:157757 )

• differentiation into CD4 or CD8 single positive thymocytes is reduced compared to in wild-type mice

increased double-positive T cell number ( J:157757 )

decreased T cell number ( J:157757 )

• peripheral T cells are reduced compared to in wild-type mice

• in transplantation experiments, T cells are less competitive than wild-type T cells

decreased CD4-positive, alpha-beta T cell number ( J:157757 )

• in the thymus

decreased CD8-positive, alpha-beta T cell number ( J:157757 )

• in the thymus

decreased single-positive T cell number ( J:157757 )

• CD4+ thymocytes are more profoundly decreased than CD8+ thymocytes

abnormal T cell activation ( J:157757 )

• mice exhibit an increase in T cell activation compared with wild-type mice

• however, activation phenotype is not cell intrinsic

decreased T cell proliferation ( J:157757 )

• however, treatment with PMA/ionomycin restores proliferation

abnormal regulatory T cell physiology ( J:157757 )

• YFP+ T regulatory cells exhibit reduced ability to suppress naive T cell proliferation compared with wild-type T cells

integument

dermatitis ( J:157757 )

• mice exhibit dermatitis unlike wild-type mice

• however, treatment with wild-type T regulatory cells prevents development of symptom

alopecia ( J:157757 )

• mice exhibit alopecia unlike wild-type mice

• however, treatment with wild-type T regulatory cells prevents development of symptom

cellular

increased T cell apoptosis ( J:157757 )

• following reactivation

decreased T cell proliferation ( J:157757 )

• however, treatment with PMA/ionomycin restores proliferation

Allelic Composition	Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0
Genetic Background	involves: 129X1/SvJ * C57BL/6 * DBA/2

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

thymus hyperplasia ( J:157757 )

• in male mice, which undergo negative selection, compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

decreased double-negative T cell number ( J:157757 )

• in male mice, which undergo negative selection, compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

increased double-positive T cell number ( J:157757 )

• in male mice, which undergo negative selection, compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

decreased CD8-positive, alpha-beta T cell number ( J:157757 )

• female mice, which undergo positive selection, exhibit a decrease in total CD8 single positive cells and CD8 single positive cells in the T3-70^hi cell compartment compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

increased CD8-positive, alpha-beta T cell number ( J:157757 )

• male mice, which undergo negative selection, exhibit an increase in CD8 single positive cells in the T3-70^hi cell compartment compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

hematopoietic system

thymus hyperplasia ( J:157757 )

• in male mice, which undergo negative selection, compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

decreased double-negative T cell number ( J:157757 )

• in male mice, which undergo negative selection, compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

increased double-positive T cell number ( J:157757 )

• in male mice, which undergo negative selection, compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

decreased CD8-positive, alpha-beta T cell number ( J:157757 )

increased CD8-positive, alpha-beta T cell number ( J:157757 )

endocrine/exocrine glands

thymus hyperplasia ( J:157757 )

• in male mice, which undergo negative selection, compared with Plcg1^tm1Gcrp/Plcg1⁺ Tg(CD4-cre)1Cwi Tg(TcraH-Y,TcrbH-Y)71Vbo mice

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/17/2024 MGI 6.24